Naoero vs North Macedonia: Tuberculosis treatment success rate by type
Naoero
79
in 2022
North Macedonia
79
in 2023
Naoero rank
120th
North Macedonia rank
120th
Tuberculosis treatment success rate by type over time
- Naoero
- North Macedonia
How they compare
Naoero currently reports 79 against 79 in North Macedonia, a difference of 0.
The two have swapped places 10 times across 20 shared years of data; in 1998 it was Naoero ahead.
Naoero ranks 120th and North Macedonia ranks 120th of 194 countries.
Across the 4 decades both report, Naoero averaged higher in 1 and North Macedonia in 3.
Head to head by decade
| Decade | Naoero | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 66.5 | 80 | 13.5 | North Macedonia |
| 2000s | 76.88 | 85.38 | 8.5 | North Macedonia |
| 2010s | 79.75 | 87.62 | 7.88 | North Macedonia |
| 2020s | 85.5 | 75.5 | 10 | Naoero |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Naoero or North Macedonia?
- Naoero, at 79 against 79 in North Macedonia as of 2022.
- What is the difference in tuberculosis treatment success rate by type between Naoero and North Macedonia?
- 0, with Naoero ahead.
- How many years of comparable data are there for Naoero and North Macedonia?
- 20 years are reported by both, from 1998 to 2022.
- How do Naoero and North Macedonia rank globally for tuberculosis treatment success rate by type?
- Naoero ranks 120th and North Macedonia ranks 120th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.